The Senate passed a bill on investigative settlement for patients with chronic diseasestranslated

On Monday, the Senate adopted a bill that provides for the settlement of all high-performance medical investigations necessary to monitor patients with diabetes, rare diseases, cardiovascular, cerebrovascular, neurological or chronic kidney diseases, reports Agerpres.

The legislative initiative modifies the provisions of the Government's Emergency Ordinance no. 44/2022, which currently limits the settlement, within the monitoring of these patients, to a single high-performance or nuclear medicine investigation per calendar year.

Settlement according to medical recommendations According to the adopted project, insured patients with the mentioned conditions will be able to benefit from the settlement of all investigations necessary for monitoring, among those included in the basic medical services package.

The legislative text provides that the investigations are granted "according to the indication of the specialist doctor", both for the monitoring of the basic disease and for the evaluation of other intercurrent conditions, under the conditions established by the package of medical services.

The measure targets high-performance and nuclear medicine investigations carried out on an outpatient basis, in…